Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ATR Protein, Human, Recombinant (GST)

Catalog No. TMPC-00055 Copy Product Info
ATR Protein, Human, Recombinant (GST) is expressed in Baculovirus-Insect Cells. The accession number is Q13535.

ATR Protein, Human, Recombinant (GST)

Catalog No. TMPC-00055
Copy Product Info

ATR Protein, Human, Recombinant (GST) is expressed in Baculovirus-Insect Cells. The accession number is Q13535.

ATR Protein, Human, Recombinant (GST)
Pack SizePriceUSA StockGlobal StockQuantity
20 μg$987InquiryInquiry
Add to Cart
Add to Quotation
For In stock only · Estimated delivery:USA Stock (1-2 days) Global Stock (5-7 days)
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
View More

Batch Information

Product Information

Biological Activity
Activity has not been tested. It is theoretically active, but we cannot guarantee it.
Description
ATR Protein, Human, Recombinant (GST) is expressed in Baculovirus-Insect Cells. The accession number is Q13535.
Species
Human
Expression System
Baculovirus-Insect Cells
TagN-GST
Accession NumberQ13535
Synonyms
Serine/threonine-protein kinase ATR,FRP1,FRAP-related protein 1,ATR,Ataxia telangiectasia and Rad3-related protein
Construction
Recombinant human ATR (2245-end) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.
Protein Purity
>70% as determined by SDS-PAGE.
ATR Protein, Human, Recombinant (GST)
Molecular Weight~70 kDa
FormulationSupplied as sterile 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, 25% glycerol.
Stability & Storage
Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
ShippingEnzymes are highly recommended to be shipped at frozen temperature with dry ice. Shipment made at ambient temperature may seriously affect the activity of the ordered products.
Research Background
ATR is a serine/threonine protein kinase and ATR kinase inhibitors potentiate chemotherapy and radiation. The ATR kinase inhibitor VX-970 (NSC 780162) is in clinical development in combination with primary cytotoxic agents and as a monotherapy for tumors harboring specific mutations. Nucleotide excision repair (NER) is the sole mechanism of UV-induced DNA lesion repair in mammals. A single round of NER requires multiple components including seven core NER factors, xeroderma pigmentosum A-G (XPA-XPG), and many auxiliary effector proteins including ATR serine/threonine kinase. The ataxia telangiectasia mutated serine/threonine kinase (ATM)/checkpoint kinase 2 (CHEK2, best known as CHK2) and the ATM and Rad3-related serine/threonine kinase (ATR)/CHEK1 (best known as CHK1) cascades are the 2 major signaling pathways driving the DNA damage response (DDR), a network of processes crucial for the preservation of genomic stability that act as a barrier against tumorigenesis and tumor progression.

Citations

Calculator

  • Reconstitution Calculator
  • Recombinant Protein Dilution Calculator
  • Specific Activity Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please read the User Guide of Recombinant Proteins for more specific information.